Galapagos NV (GLPG)
$203.78 1.08 (0.53%)
10:38 EDT GLPG Stock Quote Delayed 20 Minutes
Previous Close $202.70
Market Cap 10.46B
PE Ratio -
Volume (Avg. Vol.) 25,297
Day's Range 202.49 - 204.67
52-Week Range 110.92 - 274.03
Dividend & Yield N/A (N/A)
GLPG Stock Predictions, Articles, and Galapagos NV News
- From InvestorPlace
- From the Web
The long-term outlook is rosy for these five biotech stocks. They have the pipelines, partners and marketed drugs to provide years of growth for investors.
Not all high-priced stocks have earned their valuations. But these seven stocks to buy are great despite their price tags.
The market is hot, but that’s no reason to forgo quality when picking the top stocks to buy now. Here are seven that stand out from the rest.
It was quiet for the Nasdaq today, but bitcoin, Facebook's Libra and the Broadcom-Symantec deal were in focus.
A Galapagos deal with Gilead that includes a collaboration and an investment in the company has GLPG stock heading higher on Monday.
There are plenty of potential in clinical-stage biotech stocks. Here are five with some wonderful catalysts.
After the market's rout, biotech stocks offer a huge value right now. Here are 5 that offer the best opportunities for investors.
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
Gilead Sciences (GILD) stock is a bargain at these prices. Traders just have yet to see the glass as half full.
Navellier RatingsPowered by Portfolio Grader